Cost-effectiveness analysis of peginterferon beta-1a in the treatment of relapsing-remitting multiple sclerosis in Ireland

Category Systematic review
JournalValue in Health
Year 2015
This article has no abstract
Epistemonikos ID: 10623eea6e4a80b2f63e69f21661403aab89e9bd
First added on: Feb 07, 2025